封面
市場調查報告書
商品編碼
1980785

全球影像導航放射治療市場規模、佔有率、趨勢和成長分析報告(2026-2034年)

Global Image Guided Radiotherapy Market Size, Share, Trends & Growth Analysis Report 2026-2034

出版日期: | 出版商: Value Market Research | 英文 140 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

影像導航放射治療市場預計將從 2025 年的 26.8 億美元成長到 2034 年的 52.2 億美元,2026 年至 2034 年的複合年成長率為 7.69%。

隨著先進癌症治療技術的日益普及,全球影像導航放射治療市場正經歷強勁成長。影像導航放射治療(IGRT)是一種利用影像技術在治療過程中精準標靶腫瘤的特殊放射線治療技術。這種方法在最大限度減少對周圍健康組織的損傷的同時,也能改善治療效果。

癌症患者數量的不斷增加以及對精準微創治療方法日益成長的需求是市場成長的主要驅動力。 CT電腦斷層掃描、MRI和錐狀射束成像等影像系統的技術進步正在提高放射治療的精確度。醫院和癌症治療中心正擴大採用影像導引放射治療(IGRT)系統來改善治療效果和效率。

未來幾年,隨著腫瘤治療技術的不斷發展,全球影像導航放射治療市場預計將顯著成長。製造商正致力於開發整合成像和放射治療的系統,以便在治療過程中提供即時引導。隨著對癌症治療基礎設施和先進醫療技術投資的不斷增加,該市場預計將迎來顯著成長。

目錄

第1章:引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章:全球影像導航放射治療市場:依產品類型分類

  • 市場分析、洞察與預測
  • 放射治療/直線加速器(線性加速器)設備
  • 醫療影像設備

第5章:全球影像導航放射治療市場:依應用領域分類

  • 市場分析、洞察與預測
  • 乳癌
  • 肺癌
  • 腦腫瘤
  • 攝護腺癌
  • 胃腸道癌症
  • 婦科癌症
  • 其他用途

第6章:全球影像導航放射治療市場:依最終用途分類

  • 市場分析、洞察與預測
  • 醫院
  • 放射治療中心
  • 其他最終用戶

第7章 全球影像導航放射治療市場:按地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴(根據現有資訊)
  • 市場佔有率和市場定位分析(基於現有資訊)
  • 供應商情況(基於現有資訊)
  • 策略規劃

第9章:公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Accuray Incorporated
    • C-RAD
    • Elekta
    • GE Healthcare
    • Hitachi Ltd
    • Philips
    • Siemens Healthineers
    • Varian Medical Systems Inc
    • ViewRay Inc
    • Vision RT Ltd
簡介目錄
Product Code: VMR112115403

The Image Guided Radiotherapy Market size is expected to reach USD 5.22 Billion in 2034 from USD 2.68 Billion (2025) growing at a CAGR of 7.69% during 2026-2034.

The Global Image Guided Radiotherapy Market is witnessing strong growth as advanced cancer treatment technologies gain wider adoption. Image-guided radiotherapy (IGRT) is a specialized radiation therapy technique that uses imaging technologies to precisely target tumors during treatment. This approach helps minimize damage to surrounding healthy tissues while improving treatment effectiveness.

Increasing prevalence of cancer and the growing demand for precise and minimally invasive treatment methods are major factors driving market growth. Technological advancements in imaging systems such as CT scans, MRI, and cone-beam imaging are enhancing the accuracy of radiotherapy procedures. Hospitals and cancer treatment centers are increasingly adopting IGRT systems to improve patient outcomes and treatment efficiency.

In the coming years, the Global Image Guided Radiotherapy Market is expected to experience significant expansion as oncology care continues to evolve. Manufacturers are focusing on developing integrated imaging and radiation therapy systems that provide real-time guidance during treatment. With increasing investments in cancer treatment infrastructure and advanced medical technologies, the market is projected to grow substantially.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

  • Radiotherapy/Linac (Linear Accelerators) Devices
  • Imaging Devices

By Application

  • Breast Cancer
  • Lung Cancer
  • Brain Tumor
  • Prostate Cancer
  • Gastrointestinal Cancer
  • Gynecological Cancer
  • Other Applications

By End-Use

  • Hospitals
  • Radiotherapy Centers
  • Other End-Users

COMPANIES PROFILED

  • Accuray Incorporated, CRAD, Elekta, GE Healthcare, Hitachi Ltd, Philips, Siemens Healthineers, Varian Medical Systems Inc, ViewRay Inc, Vision RT Ltd
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL IMAGE GUIDED RADIOTHERAPY MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product Type
  • 4.2. Radiotherapy/Linac (Linear Accelerators) Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Imaging Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL IMAGE GUIDED RADIOTHERAPY MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Application
  • 5.2. Breast Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Lung Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Brain Tumor Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Prostate Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.6. Gastrointestinal Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.7. Gynecological Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.8. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL IMAGE GUIDED RADIOTHERAPY MARKET: BY END-USE 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End-use
  • 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Radiotherapy Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Other End-Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL IMAGE GUIDED RADIOTHERAPY MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Product Type
    • 7.2.2 By Application
    • 7.2.3 By End-use
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Product Type
    • 7.3.2 By Application
    • 7.3.3 By End-use
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Product Type
    • 7.4.2 By Application
    • 7.4.3 By End-use
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Product Type
    • 7.5.2 By Application
    • 7.5.3 By End-use
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Product Type
    • 7.6.2 By Application
    • 7.6.3 By End-use
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL IMAGE GUIDED RADIOTHERAPY INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Accuray Incorporated
    • 9.2.2 C-RAD
    • 9.2.3 Elekta
    • 9.2.4 GE Healthcare
    • 9.2.5 Hitachi Ltd
    • 9.2.6 Philips
    • 9.2.7 Siemens Healthineers
    • 9.2.8 Varian Medical Systems Inc
    • 9.2.9 ViewRay Inc
    • 9.2.10 Vision RT Ltd